Wires

Meningitis-linked firm told regulators its drugs were safe -FDA

Share

WASHINGTON, Oct 11 (Reuters) - The New England CompoundingCenter, the pharmacy at the heart of a deadly meningitisoutbreak, assured federal health officials that it was producingsafe products, according to regulators, who said on Thursdaythat the firm appears to have violated its state licensingrequirements.

(Reporting by David Morgan; Editing by Sandra Maler)

((david.morgan@thomsonreuters.com)(+1)(202)(898 8326)())

Keywords: USA HEALTH/MENINGITIS REGULATORS